Johnson & Johnson said it is acquiring Halda Therapeutics, a developer of cancer drugs, for $3.05 billion. Halda’s lead ...

Novo Nordisk has begun selling Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump ...

The toll from cervical cancer is highest in lower-income countries, which often lack screening programs that can result in ...

Nuvalent said its drug for ALK+ lung cancer shrank tumors in more than a quarter of patients whose disease had returned after ...

WuXi AppTec, the Chinese pharma giant with extensive ties with U.S. companies, appears to be thriving now that the threat of ...

ROAI isn't about flashy demos or model size. It's about measurable improvements,” writes Sanofi CEO Paul Hudson.

We both lost our jobs as public health diplomats with the U.S. Agency for International Development last summer. Our termination from federal service also meant that both of us lo ...

During a two-hour experimental chat with a therapist chatbot character, it “actively encouraged me to disregard my ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.

Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...

When the Supreme Court struck down the federal ban on sports betting in 2018, Americans legally wagered less than $5 billion ...